Breaking

Cancer Drug Derived From Himalayan 'Caterpillar Fungus' Smashes Early Clinical Trial - ScienceAlert
Oct 12, 2021 28 secs

NUC-7738, synthesized by researchers at the University of Oxford in partnership with UK-based biopharmaceutical company NuCana, is still in the experimental testing stages and isn't available as an anti-cancer medication yet – but newly reported clinical trial results bode well for the drug candidate.

According to a new study on NUC-7738, these changes make the drug candidate's anti-cancer properties up to 40 times more potent than cordycepin when tested against a range of human cancer cell lines.

While it's certainly a promising start, it will still be some time before NUC-7738 becomes available to patients outside the trial.

RECENT NEWS

SUBSCRIBE

Get monthly updates and free resources.

CONNECT WITH US

© Copyright 2024 365NEWSX - All RIGHTS RESERVED